Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.

[1]  M. Aljurf,et al.  Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen , 2009, Haematologica.

[2]  A. Gratwohl,et al.  Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report , 2009, Bone Marrow Transplantation.

[3]  A. Bacigalupo.  Treatment strategies for patients with severe aplastic anemia , 2008, Bone Marrow Transplantation.

[4]  P. Armand,et al.  Allogeneic stem cell transplantation for aplastic anemia. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  B. George,et al.  Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia , 2007, Bone Marrow Transplantation.

[6]  P. Tsirigotis,et al.  Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine‐based preparative regimen , 2006, British journal of haematology.

[7]  N. Geller,et al.  Overcoming graft rejection in heavily transfused and allo‐immunised patients with bone marrow failure syndromes using fludarabine‐based haematopoietic cell transplantation , 2006, British journal of haematology.

[8]  Ravi Kumar,et al.  Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia , 2006, Bone Marrow Transplantation.

[9]  J. Vela-Ojeda,et al.  Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine‐based conditioning regimen: The Mexican experience , 2006 .

[10]  S. Shapiro,et al.  The epidemiology of aplastic anemia in Thailand. , 1999, Blood.

[11]  F. Locatelli,et al.  Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party , 2005, Bone Marrow Transplantation.

[12]  G. Hale,et al.  Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  H. Shin,et al.  Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia , 2004, Bone Marrow Transplantation.

[14]  P. Parikh,et al.  Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia. , 2003, The Journal of the Association of Physicians of India.

[15]  K. Chik,et al.  A fludarabine-based conditioning regimen for severe aplastic anemia , 2001, Bone Marrow Transplantation.

[16]  M. Kamel,et al.  Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation , 1999, Bone Marrow Transplantation.

[17]  H. Deeg,et al.  Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. , 1996, Blood.

[18]  H. Deeg,et al.  Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. , 1994, Blood.

[19]  B. Cheson,et al.  Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .